Linden Thomas Advisory Services, LLC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1965702 Charlotte, NC

Position in CPRX

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$5,531,805

+$1,481,292 QoQ

Shares Held

176,004

+7.6% QoQ

Ownership

0.144%

of shares outstanding

% of Portfolio

0.45%

of 13F equity value

Holder Rank

of 75 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $36,440,714 across 14 Biotechnology names. CPRX ranks #1 (15.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc. This page	176,004	$5,531,805
2	INCY	Incyte Corp	46,507	$5,272,033
3	VRTX	Vertex Pharmaceuticals Inc / Ma	8,103	$4,025,003
4	REGN	Regeneron Pharmaceuticals, Inc.	5,106	$3,183,795
5	EXEL	Exelixis, Inc.	57,943	$3,152,678
6	LGND	Ligand Pharmaceuticals Inc	9,935	$3,140,354
7	CORT	Corcept Therapeutics Inc	34,641	$3,012,034
8	VCEL	Vericel Corp	56,051	$2,493,708

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,531,805	176,004	+7.6%	Shares	Sole	2026-07-16
2026-03-31	$4,050,513	163,591	+16.9%	Shares	Sole	2026-04-10
2025-12-31	$3,265,219	139,898	+3.2%	Shares	Sole	2026-01-16
2025-09-30	$2,670,945	135,581	+6.4%	Shares	Sole	2025-11-06
2025-06-30	$2,765,144	127,426	+261.7%	Shares	Sole	2025-07-31
2025-03-31	$854,400	35,233	+7.9%	Shares	Sole	2025-04-30
2024-12-31	$681,175	32,639	+21.3%	Shares	Sole	2025-01-21
2024-09-30	$534,911	26,907	+26.2%	Shares	Sole	2024-10-17
2024-06-30	$330,339	21,326	+27.4%	Shares	Sole	2024-07-10
2024-03-31	$266,883	16,743	+51.2%	Shares	Sole	2024-04-30
2023-12-31	$186,204	11,077	—	Shares	Sole	2024-02-01
No filing history on record for this holder in this stock.